In conclusion, initiation of SGLT2 inhibitors in patients with AHF significantly decrease the urinary AKI risk markers TIMP-2 and IGFBP7 within the first week, supporting the protective effect of SGLT2 inhibitor on renal tubular injury. Here, TIMP2 is linked to acute kidney injury.